CORE-ATMP: Cutting edge Optimization and Research Enhancements for Advanced Therapy Medicinal Products
Enhancing advanced therapy development through collaborative research and standardized methodologies towards First-in-Human trials
CORE-ATMP: Enhancing Research and Development for Cell and Gene Therapy
The CORE-ATMP project unites key institutions—Leiden University Medical Center (LUMC), the Centre for Human Drug Research (CHDR), the Central Committee on Research Involving Human Subjects (CCMO), and the Dutch Medicines Evaluation Board (CBG)—in a public-private partnership dedicated to advancing the development of cell and gene therapies with the aim to streamline the transition from the laboratory to clinical trials. These innovative therapies promise effective treatments for severe genetic diseases and cancer by targeting the conditions at their source.
Cell and gene therapies represent transformative advancements in treating serious health conditions, yet their development faces challenges, such as complex safety and efficacy requirements. The societal and economic impacts of genetic diseases and cancer are profound, with millions affected worldwide. Innovation in therapy development is needed to provide developers with clear methodologies and patients with timely, effective treatments.
Addressing these challenges, CORE-ATMP is pioneering advanced methodologies to ensure a robust and predictable transition into clinical trials. CORE-ATMP deliverables include validated methodologies for potency assays and non-clinical data evaluation supporting a well-considered and reliable approach to first-in-human application. These resources are being made freely available to researchers, regulatory bodies, and developers, ensuring widespread access to the latest advancements in therapy development. This will foster broad adoption and implementation. These tools are expected to reduce development timelines through harmonization and improved treatment reliability, and ultimately, enhance patient access to safe and effective therapies. Through this collaborative effort, CORE-ATMP exemplifies how partnerships can bridge gaps between research and clinical application, leading to significant health advancements.
Other projects
In each PPP project, research institutions, businesses and healthcare organisations work together on a specific health challenge. Browse the full project overview.
Bekijk de programma’s
Binnen onze programma’s werken bedrijven, kennisinstellingen en regionale partners samen aan innovaties die bijdragen aan betere gezondheid en zorg.
Bekijk de partnerschappen
Strategische publiek-private partnerschappen (PPP's) zijn meerjarige samenwerkingen tussen bedrijven, kennisinstellingen en andere partijen.
Hoe kunnen we je helpen?
Heb je een vraag of wil je meer weten over Health Holland? We brengen je graag in contact met de juiste mensen, kennis en mogelijkheden om gezondheidsinnovatie te versnellen.
We have received your message
We will contact you within 3 to 4 working days. If your question is urgent, please contact us directly. Below is the contact option that best matches your subject.
Start again
Something went wrong while sending the form. Please try again.